American Portfolios Advisors’s Rockwell Medical RMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$684 Hold
52
﹤0.01% 3340
2022
Q2
$668 Hold
52
﹤0.01% 3353
2022
Q1
$2.7K Hold
52
﹤0.01% 3151
2021
Q4
$2.35K Hold
52
﹤0.01% 3134
2021
Q3
$3.41K Hold
52
﹤0.01% 2995
2021
Q2
$5.21K Hold
52
﹤0.01% 2793
2021
Q1
$6.63K Sell
52
-29
-36% -$4.29K ﹤0.01% 2576
2020
Q4
$8.96K Sell
81
-28
-26% -$3.13K ﹤0.01% 2156
2020
Q3
$12.8K Hold
109
﹤0.01% 1879
2020
Q2
$23.3K Buy
109
+23
+27% +$5.43K ﹤0.01% 1578
2020
Q1
$19.4K Hold
86
﹤0.01% 1537
2019
Q4
$23.1K Hold
86
﹤0.01% 1665
2019
Q3
$26.1K Buy
86
+18
+26% +$5.53K ﹤0.01% 1556
2019
Q2
$22.4K Buy
+68
New +$34.5K ﹤0.01% 1630

Other funds holding RMTI

American Portfolios Advisors's RMTI Position: Q3 2022 in Review

American Portfolios Advisors held its Rockwell Medical (RMTI) position steady in Q3 2022 at 52 shares worth $684. The position accounts for ﹤0.01% of the portfolio, ranked #3340.

American Portfolios Advisors first reported a position in RMTI in Q2 2019 and has held it in 14 quarters since. The position peaked at $26.1K in Q3 2019. 34 funds tracked by Wall St. Rank hold RMTI as of Q3 2022.

  • American Portfolios Advisors held 52 shares of Rockwell Medical worth $684 as of Q3 2022.
  • American Portfolios Advisors left its Rockwell Medical share count unchanged in Q3 2022.
  • Rockwell Medical made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3340 holding.
  • American Portfolios Advisors first reported a position in Rockwell Medical in Q2 2019 and has held it in 14 quarters since.
  • American Portfolios Advisors's Rockwell Medical position peaked at $26.1K in Q3 2019.
  • 34 funds tracked by Wall St. Rank held Rockwell Medical as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.